Hem › Akut bifentypisk leukemi › Virginia › Charlottesville
Kliniska studier för Akut bifentypisk leukemi i Charlottesville, VA
3 studier för Akut bifentypisk leukemi söker deltagare vid platser i och runt Charlottesville (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekryterarFas 2
- University of Virginia Cancer Center, Charlottesville
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekryterarFas 3
- University of Virginia Cancer Center, Charlottesville
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekryterarFas 1/2
- University of Virginia Cancer Center, Charlottesville
Akut bifentypisk leukemi-studier i andra städer
- Seattle, WA15 studier
- Houston, TX11 studier
- New York City, NY10 studier
- Atlanta, GA9 studier
- Durham, NC8 studier
- Memphis, TN7 studier
- Chicago, IL7 studier
- Charlotte, NC6 studier
- Aurora, CO6 studier
- Baldwin Park, CA6 studier
- Portland, OR6 studier
- Los Angeles, CA6 studier
Andra studier i Charlottesville
- Icke-småcellig lungcancer21 studier
- Akut myeloid leukemi16 studier
- Prostatacancer15 studier
- Metastaserande cancer13 studier
- Endometriecancer13 studier
- Cancer (alla typer)13 studier
- Lungcancer13 studier
- Hjärtsvikt11 studier
- Äggstockscancer10 studier
- Kolorektal cancer10 studier
- Typ 1-diabetes9 studier
- Bröstcancer9 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.